Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: Implications in immunotherapy and vaccination strategies

Molecular Immunology

Volumn 43, Issue 6, 2006, Pages 667-676

  Dela Cruz, Jay Soriano ^a   Trinh, Kamh Ryan ^a   Chen, Hsiao Wen ^a   Ribas, Antoni ^a   Morrison, Sherie L ^a   Penichet, Manuel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antibody fusion proteins; Cancer; Cytokine; HER2 neu; Immunotherapy

Indexed keywords

CANCER VACCINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 ANTIBODY IMMUNOGLOBULIN G3 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2 ANTIBODY IMMUNOGLOBULIN G3 INTERLEUKIN 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2 IMMUNOGLOBULIN G3; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYBRID PROTEIN; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G3 GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G3 INTERLEUKIN 2; INTERLEUKIN 2; OVALBUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL SPECIFICITY; CELL TRANSPORT; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; ENDOSOME; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE; TUMOR IMMUNITY; VACCINATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; DENDRITIC CELLS; ENDOSOMES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNITY; IMMUNOGLOBULIN G; IMMUNOTHERAPY; INTERLEUKIN-2; MICE; MICE, INBRED BALB C; OVALBUMIN; RECEPTOR, ERBB-2; RECOMBINANT FUSION PROTEINS; VACCINATION;

ANIMALIA; MURINAE;

EID: 28944435863     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2005.04.007     Document Type: Article

References (33)

1. C.F. Anderson, and D.M. Mosser Cutting edge: biasing immune responses by directing antigen to macrophage Fc gamma receptors J. Immunol. 168 2002 3697 3701
2. D.Z. Chang, Z. Wu, and T.L. Ciardelli A point mutation in interleukin-2 that alters ligand internalization J. Biol. Chem. 271 1996 13349 13355
3. T.T. Chen, M.H. Tao, and R. Levy Idiotype-cytokine fusion proteins as cancer vaccines: relative efficacy of IL-2, IL-4, and granulocyte-macrophage colony-stimulating factor J. Immunol. 153 1994 4775 4787
4. J.S. Dela Cruz, S.Y. Lau, E.M. Ramirez, C. De Giovanni, G. Forni, S.L. Morrison, and M.L. Penichet Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice Vaccine 21 2003 1317 1326
5. J.S. Dela Cruz, K.R. Trinh, S.L. Morrison, and M.L. Penichet Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity J. Immunol. 165 2000 5112 5121
6. Dela Cruz, J.S., Morrison, S.L., Penichet, M.L., in press. Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein. Vaccine.
7. M.L. Disis, K.H. Grabstein, P.R. Sleath, and M.A. Cheever Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine Clin. Cancer Res. 5 1999 1289 1297
8. M.L. Disis, J.R. Gralow, H. Bernhard, S.L. Hand, W.D. Rubin, and M.A. Cheever Peptide-based, but not whole protein, vaccines elicit immunity to HER-2/neu, oncogenic self-protein J. Immunol. 156 1996 3151 3158
9. V. Duprez, M. Smoljanovic, M. Lieb, and A. Dautry-Varsat Trafficking of interleukin 2 and transferrin in endosomal fractions of T lymphocytes J. Cell Sci. 107 Pt. 5 1994 1289 1295
10. L. Faulkner, G. Buchan, E. Lockhart, L. Slobbe, M. Wilson, and M. Baird IL-2 linked to a peptide from influenza hemagglutinin enhances T cell activation by affecting the antigen-presentation function of bone marrow-derived dendritic cells Int. Immunol. 13 2001 713 721
11. E.T. Harvill, J.M. Fleming, and S.L. Morrison In vivo properties of an IgG3-IL-2 fusion protein: a general strategy for immune potentiation J. Immunol. 157 1996 3165 3170
12. D.F. Hayes, H. Yamauchi, G. Broadwater, C.T. Cirrincione, S.P. Rodrigue, D.A. Berry, J. Younger, L.L. Panasci, F. Millard, D.B. Duggan, L. Norton, and I.C. Henderson Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: cancer and leukemia group B study 8662 Clin.Cancer Res. 7 2001 2703 2711
13. M. Hazama, A. Mayumi-Aono, N. Asakawa, S. Kuroda, S. Hinuma, and Y. Fujisawa Adjuvant-independent enhanced immune responses to recombinant herpes simplex virus type 1 glycoprotein D by fusion with biologically active interleukin-2 Vaccine 11 1993 629 636
14. M. Hazama, A. Mayumi-Aono, T. Miyazaki, S. Hinuma, and Y. Fujisawa Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2 Immunology 78 1993 643 649
15. A. Hemar, A. Subtil, M. Lieb, E. Morelon, R. Hellio, and A. Dautry-Varsat Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains J. Cell. Biol. 129 1995 55 64
16. E.M. Hiltbold, A.M. Vlad, P. Ciborowski, S.C. Watkins, and O.J. Finn The mechanism of unresponsiveness to circulating tumor antigen MUC1 is a block in intracellular sorting and processing by dendritic cells J. Immunol. 165 2000 3730 3741
17. J.W. Lowenthal, H.R. MacDonald, and B.J. Iacopetta Intracellular pathway of interleukin 2 following receptor-mediated endocytosis Eur. J. Immunol. 16 1986 1461 1463
18. M.B. Lutz, C.U. Assmann, G. Girolomoni, and P. Ricciardi-Castagnoli Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line Eur. J. Immunol. 26 1996 586 594
19. M.L. Penichet, P.M. Challita, S.U. Shin, S.L. Sampogna, J.D. Rosenblatt, and S.L. Morrison In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice Lab. Anim. Sci. 49 1999 179 188
20. M.L. Penichet, J.S. Dela Cruz, S.U. Shin, and S.L. Morrison A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors Hum. Antibodies 10 2001 43 49
21. J. Pieters Entry and survival of pathogenic mycobacteria in macrophages Microbes Infect. 3 2001 249 255
22. A. Ribas, L.H. Butterfield, W.H. McBride, V.B. Dissette, A. Koh, C.M. Vollmer, B. Hu, A.Y. Chen, J.A. Glaspy, and J.S. Economou Characterization of antitumor immunization to a defined melanoma antigen using genetically engineered murine dendritic cells Cancer Gene Ther. 6 1999 523 536
23. L.G. Salazar, J. Fikes, S. Southwood, G. Ishioka, K.L. Knutson, T.A. Gooley, K. Schiffman, and M.L. Disis Immunization of cancer patients with HER-2/neu-derived peptides demonstrating high-affinity binding to multiple class II alleles Clin. Cancer Res. 9 2003 5559 5565
24. D.H. Schuurhuis, A. Ioan-Facsinay, B. Nagelkerken, J.J. van Schip, C. Sedlik, C.J. Melief, J.S. Verbeek, and F. Ossendorp Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo J. Immunol. 168 2002 2240 2246
25. D.J. Slamon, G.M. Clark, S.G. Wong, W.J. Levin, A. Ullrich, and W.L. McGuire Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene Science 235 1987 177 182
26. A. Subtil, A. Hemar, and A. Dautry-Varsat Rapid endocytosis of interleukin 2 receptors when clathrin-coated pit endocytosis is inhibited J. Cell Sci. 107 Pt. 12 1994 3461 3468
27. M.H. Tao, and R. Levy Idiotype/granulocyte-macrophage colony-stimulating factor fusion protein as a vaccine for B-cell lymphoma Nature 362 1993 755 758
28. S.G. Turville, J.J. Santos, I. Frank, P.U. Cameron, J. Wilkinson, M. Miranda-Saksena, J. Dable, H. Stossel, N. Romani, M. Piatak Jr., J.D. Lifson, M. Pope, and A.L. Cunningham Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells Blood 103 2004 2170 2179
29. V. Visco, R. Bei, E. Moriconi, W. Gianni, M.H. Kraus, and R. Muraro ErbB2 immune response in breast cancer patients with soluble receptor ectodomain Am. J. Pathol. 156 2000 1417 1424
30. F. Walker, and A.W. Burgess Internalisation and recycling of the granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor on a murine myelomonocytic leukemia J. Cell. Physiol. 130 1987 255 261
31. A. Yada, S. Ebihara, K. Matsumura, S. Endo, T. Maeda, A. Nakamura, K. Akiyama, S. Aiba, and T. Takai Accelerated antigen presentation and elicitation of humoral response in vivo by FcgammaRIIB- and FcgammaRI/III-mediated immune complex uptake Cell Immunol. 225 2003 21 32
32. Y. Yarden, and M.X. Sliwkowski Untangling the ErbB signalling network Nat. Rev. Mol. Cell Biol. 2 2001 127 137
33. A. Yu, and T.R. Malek The proteasome regulates receptor-mediated endocytosis of interleukin-2 J. Biol. Chem. 276 2001 381 385